Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms 4Leukemia, Myeloid, Acute 3Carcinoma 3Small Cell Lung Carcinoma 1Sarcoma, Myeloid 1Myelodysplastic Syndromes 1Leukemia 1Hematologic Diseases 1Carcinoma, Small Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma 1Acute Disease 1

Interventions

Pemetrexed 3Gemcitabine 3Topotecan 2Carboplatin 2vosaroxin 1vinflunine 1taxane 1pembrolizumab 1lurtotecan 1liposomal doxorubicin 1enzalutamide 1bemiparin 1apalutamide 1abiraterone 1Vinorelbine 1Temozolomide 1RRx-001 1Paclitaxel 1Nivolumab 1Irinotecan 1Ipilimumab 1Etoposide 1Docetaxel 1Cisplatin 1BI 2536 1Arsenic Trioxide 1ARQ 197 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Small Cell × vosaroxin × Clear all
NCT00298896 2018-07-26

Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer

Sunesis Pharmaceuticals

Phase 2 Completed
55 enrolled 10 charts
Thoracic

Carcinoma, Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡